chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Injection given 9/19/22 at 1215, at 1815 sore throat and temperature of 100.4, at 2000 mild injection site pain and warmth at injection site, headache, runny nose, fatigue. 9/20/22 at 0430, all previous symptoms still there and pain in shoulder of arm where injection was given. By 1600, extreme fatigue, muscle & joint pain, cough, nasal congestion, heaviness in chest. Temperature 100.8 at 2000.
Client complained feeling dizzy. EMS attended client, took vitals and suggested for him to drink a bottle of water. He was observed for 25 minutes.  BP was 105/55 and Ox 99%. Released at 1725.
Red, hot lump apporximately 3" of right upper arm. Fever of 101.3 degrees. extremely painful swollen lymph nodes along right collar bone. All present by about 9:00am the morning following the flu shot.
Information has been received from a licensed practical nurse concerning a female (age not reported) with no relevant medical history who on 06-NOV-2006 was vaccinated intramuscularly with a 0.5 mL dose of Pneumovax 23 (lot 651400/0618F). There was no concomitant medication. On 06-NOV-2006, the patient developed soreness and pain at the injection site 3 hours after receiving the vaccination. The pain may have spread to her back. The patient returned to the clinic, and the injection site arm was described as sore and painful, but not red or hot. The patient received an unspecified injection for the pain on the return visit to the clinic on 06-NOV-2006. The patient recovered the next day on 07-NOV-2006. The reporter requested a lot check be performed on lot 651400/0618F. The records of testing prior to release of the lot in question have been rechecked and found to be satisfactory. The lot complies with the government agency and was released. Additional information has been requested.
Pt recv vax in 12/98; on 2/5/99 pt exp shingles on rt arm
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a male patient of unknown age. No information was provided regarding medical history, concurrent conditions, or concomitant medications. On 20-FEB-2014, the patient was inoculated with ZOSTAVAX from his primary care physician for routine health maintenance and for the prevention of shingles (route, dose, and lot # not provided). The vaccine did not prevent shingles, but rather caused the patient to contract a persistent and severe strain of herpes zoster. Shortly after receiving ZOSTAVAX (date not further specified), the patient was diagnosed with shingles inside his ears, which contributed to left ear hearing loss, pain and issues with balance. On 17-JUN-2016, the patient presented to an ear, nose, and throat/allergy physician with these complaints and was diagnosed as suffering from sudden left sensorineural hearing loss (also abbreviated by the lawyer as "SNHL"). Thereafter, on an unspecified date, the patient was hospitalized and was diagnosed as suffering from Ramsay Hunt Syndrome. At the time of the report (reported as "currently"), the patient continued to suffer from pronounced left ear hearing loss, sensitivity to sound, difficulty swallowing, and issues with balance. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, he has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The lawyer considered the events to be related to ZOSTAVAX. The events were not recovered at the time of reporting. Upon internal review, persistent and severe strain of herpes zoster/shingles inside the ears which contributed to left ear hearing loss, pain, and issues with balance/Ramsay Hunt Syndrome was considered medically significant. Additional information has been requested.
Dizziness, shortness of breath, almost fainted, rapid heart rate.  Treated in ER for AFIB, hospitalized.  Normal rhythm returned after 20 hours and a variety of medications.
Muscle pain in both calf muscles starting 2 days after first shot. Pins and needles feeling in my feet which progressed to my arms and hands. Balance issues. Unable to walk without cane. Diagnosed with Peripheral neuropathy and Cerebellar Ataxia
My son was vaccinated he just had a sore arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the parent.  A 12 year-old male patient received bnt162b2 (BNT162B2), administered in arm right, administration date 26Jun2021 09:30 (Lot number: EW0150, Expiration Date: 31Jul2021) at the age of 12 years as dose number unknown, single for covid-19 immunisation. Relevant medical history included: "Autistic" (unspecified if ongoing), notes: Verbatim: Autistic. Concomitant medication(s) included: ZOLOFT taken for autism spectrum disorder. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "My son was vaccinated he just had a sore arm".  Additional information: The reporter is the mother of the patient. The reporter stated, she got her kids vaccinated yesterday (26Jun2021), my oldest daughter who was 15 and she had blurry vision and lost her hearing briefly for few minute on the day of reporting morning, so the reporter just got like that it was a side effect that probably should be reported, and her hearing came back in to, lying on the couch right then.  The reporter stated that she was vaccinated, haven't side effect. The patient (reporter's son) was vaccinated he just had a sore arm, but her daughter had this blurred vision and lost her hearing this morning so she thought it was, and report it. When probed for vaccination and side effects details of patient, the reporter stated, yes, right, the patient had stop talking more about that and he had not complained about anything that the reporter knew. The reporter said the patient had no prior vaccination.   This LRN W2021388963 is cross linked with W2021388964. The report is cross referenced to report ID:   No follow-up attempts are possible. No further information is expected.
Pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Pregnant) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 21-Jan-2021, the patient experienced EXPOSURE DURING PREGNANCY (Pregnant). On 21-Jan-2021, EXPOSURE DURING PREGNANCY (Pregnant) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment related information has been reported.
Red injection site, itchy injection site, hot injection site. Benadryl used to treat the event.
Localized erythema and warmth of Left thigh starting the day after vaccination was given, persistent when seen in office 3 days after vaccination, but improving. No induration or fluctuance. No fevers
Local reaction at injection site, onset 3-5 hours post injection, large red area at injection site, swelling, warm to touch.  Ice / cool compresses applied with slight improvement next morning.  Same treatment continued with slight improvement 24 hours post injection.
Starting at 10:30 pm the night Of 3/11/2021 the back of my legs and buttocks started aching and gradually spread throughout my body. I had chills, body aches, fever, elevated heart rate,  heat flashes, and headache throughout the whole night. I could not sleep due to anxiety, which I don?t have normally. It was beyond miserable. It lasted a little over 48 hours. None of the symptoms were mild.
Expired vaccine received; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine received) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination.     Concurrent medical conditions included Food allergy.    On 24-Sep-2021 at 1:10 PM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Sep-2021 at 1:10 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine received). On 24-Sep-2021 at 1:10 PM, EXPIRED PRODUCT ADMINISTERED (Expired vaccine received) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient was allergic to Medications and other products.  Concomitant medication was not provided by the reporter. Treatment medication was not reported.  The patient did not have any adverse events and did not require any medical attention after receiving the dose.
This spontaneous report was received from a medical assistant referring to unspecified number of unspecified patients of unknown age and gender. Information about concurrent condition, concomitant medication and medical history was not provided. On unknown dates staring on or after 22-APR-2016, the patients were administered an unspecified number of improperly stored doses of RECOMBIVAX HB (lot # L030608, expiration date 15-APR-2017, lot # M003661, expiration date 15-SEP-2017) (dose and route of administration were not reported). The administered doses experienced a temperature excursion of 32 F for 2 hours and 8 minutes. No previous excursions were reported. The temperature excursions were detected by a data logger.  No adverse effect was reported. This is one of several reports received from the same reporter.
That evening high fever, chills  nausea and then few days later Bell?s palsy, face is tingling, eye won?t shut and speech hindered.
Achy especially in the arms, tired, chills no fever and hot flushes at least 7 a day.  Today is the 7 of October and the symptoms since to be going away.  The hot flushes lasted 10 minutes to the point where I was perspiring from the waist up.
pt recv vax 9SEP95 & pt devel cough & dx w/whooping cough on 5OCT95;pt was hospitalized for the whooping cough;pt had an upper resp infect x 1wk;pt seen in ER to r/o pneumonia;CXR nl;pt adm to hosp to r/o pertussis infect;
Information has been received from a registered nurse concerning a female under 18 years old who in approximately April 2007 was vaccinated with the first dose of Gardasil. Subsequently the patient experienced a rash on her complete torso. The patient was prescribed an unknown cream as treatment. The rash did not resolve by 5 days but may have resolved by now. Medical attention was sought. Additional information has been requested. This is in follow-up to report(s) previously submitted on 6/14/2007.  Information has been received from a registered nurse concerning a 15 year old female student with PENICILLIN, AMOXICILLIN and CECLOR allergies who on 19-APR-2007 at 16:23 was vaccinated intramuscularly into the right deltoid with the first dose of GARDASIL (Lot # 654702/0011U).  On 22-APR-2007, the patient felt  "cold and achy" which persisted until the p.m. of 23-APR-2007 when itchiness and a rash on her complete torso, knees and back of hands developed.  The patient was prescribed CLARINEX and LOTRISONE cream as treatment.  The rash did not resolve by 5 days.  The patient's mom called on 01-MAY-2007 and reported that the symptoms persisted.  No further information had been received since then.  Additional information is not expected.
Information has been received from a female who was vaccinated with Zostavax (Oka/Merck).  The patient developed a rash on her body a week after receiving Zostavax.  As of 14-SEP-2007, the patient had not recovered.  Additional information is not expected.
Pt had already received 2 MMR vaccines and was given a third when it was not needed/ordered. Error reported by CMA to provider. Provider indicated that there would be no adverse concerns for patient.
Headache, irregular menstrual cycle, extreme full body itching, abdominal pain, Muscle pain
Developed a mild fever, fussiness, night waking, moderate rash over face, neck and torso.
Pt was brought in by mom to receive vaccines for the first time.  After 1st 2 vaccines pt started feeling light headed. MA had patient lay down on exam table and asked mom if she wanted to proceed with other vaccines. Mom said yes. Patient looked pale and said he wanted to throw up after he received an additional 3 vaccines. At which point MA called for help. LVN came in with emesis bag and wheelchair to assist with pt. Provider came in to assess the pt. Pt stated he wanted to go home and go to sleep. LVN wheeled pt out in the wheelchair to pts car. Mother took pt home and was instructed to call or bring pt back if he's not doing better. LVN called pt @ 2:00pm to check how pt was doing. Pts mother stated pt was doing much better just a slight headache. Pts mother was offered a f/u up appt. Pts mother agreed and rescheduled for 10/02/2020. Pts mother was again instructed to call or bring pt back if she sees any other adverse reactions.
Low grade fever; Shivers; Achy; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Low grade fever), CHILLS (Shivers) and MYALGIA (Achy) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Low grade fever), CHILLS (Shivers) and MYALGIA (Achy). At the time of the report, PYREXIA (Low grade fever), CHILLS (Shivers) and MYALGIA (Achy) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication information was provided. No treatment medication information was provided.   This case was linked to MOD21-072736 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 17-May-2021: F/U received on 17-MAY-2021,Non significant follow up,Contact information updated (Email).; Sender's Comments:  MOD21-072736:
Cellulitis over left deltoid site of Dtap, IPV and MMR (given 7/20/05). Started on antibiotics.
Tired; Sore left arm; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Tired) and PAIN IN EXTREMITY (Sore left arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FATIGUE (Tired) and PAIN IN EXTREMITY (Sore left arm). At the time of the report, FATIGUE (Tired) and PAIN IN EXTREMITY (Sore left arm) outcome was unknown. Not Provided   No treatment information was provided.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Redness in the arm that came out of nowhere one day more than a week later but continues to worsen now more than 2.5 weeks later, additional body aches almost all over but especially in the torso (it feels like someone has been kicking me) and fatigue and confusion and irritability and vision and chills
This spontaneous report as received from a pharmacist refers to a patient of unknown age. On 09-NOV-2018 the patient was vaccinated with PNEUMOVAX 23 lot # N003997, intramuscular for prophylaxis. On 09-NOV-2018, 1 day after onset of therapy the patient experienced expired product administered. On an unknown date the patient experienced no adverse event. The outcome of expired product administered and no adverse event is unknown. The reporter considered expired product administered and no adverse event to be not assessed to PNEUMOVAX 23.
not reconstituted with the supplied diluent / possibly reconstituted with sterile water; patient received a dose of Hiberix that was not reconstituted with the supplied diluent; This case was reported by a other health professional via call center representative and described the occurrence of wrong solution used in drug reconstitution in a patient who received Hib (Hiberix) (batch number 4925E, expiry date 24th October 2021) for prophylaxis.   On an unknown date, the patient received Hiberix. On an unknown date, unknown after receiving Hiberix, the patient experienced wrong solution used in drug reconstitution and inappropriate dose of vaccine administered. On an unknown date, the outcome of the wrong solution used in drug reconstitution and inappropriate dose of vaccine administered were unknown.  Additional details were provided as follows: The reporter was a medical assistant. The age at vaccination was not reported. The reporter stated that the patient received a dose of Hiberix that was not reconstituted with the supplied diluent, which led to wrong solution used in drug reconstitution and inappropriate dose of vaccine administered. The reporter stated that the incorrect dose was possibly reconstituted with sterile water. The reporter consented to follow up. No further information reported. This is 1 of 4 cases reported by the same reporter. Note: All the linked cases were conservatively kept valid as the reporter was unsure which patient had received the incorrectly reconstituted dose.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR073598:same reporter US-GLAXOSMITHKLINE-US2021073386:same reporter US-GLAXOSMITHKLINE-US2021AMR073597:same reporter
After receiving the vaccine I initially started with having headaches. Those headaches intensified and became more regular through the May 2021. From the month of May till now the headaches have been 24/7. They are very intense ranging from a 4 to 9 pain level. Now I have a problem speaking, communicating, and remembering things. I also have body aches are that are 24/7 now. I am having trouble sleeping because of the intensity of the headaches when they come in the evening at night. I've seen multiple doctors and neurologists. My new doctor said it was possibly vaccine induced. I was prescribed Topamax for the headaches, but it isn't working. I have also tried over the counter medications, but those don't work either. I am scheduled to do a nerve test in two weeks.
Patient states that he had no symptoms for the first 3 days after the COVID vaccine that was given on Monday 3/29/2021, then on the 4th day Friday, 4/2/2021 he woke up with fever of 108, sweats, chills, headache and severe fatigue.  He denied shortness of breath, loss of taste or smell.  He states that these symptoms continued over a 2 week period ending on Monday 4/12/2021.  He states that he doesn't have insurance so he didn't seek medical attention. To date he feels he is now back to his normal state, but continues to be against the 2nd dose.
Pt felt light headed, then had trouble breathing with metallic taste in mouth, then swelling or pressure in the Rt eye, then nauseous.
12-year-old patient due for booster dose given Moderna booster instead of Pfizer 12+ booster.
No fever, local rxn immediately p/immun; Approx 3 days prior to rxn, pt was irritable; Awoke 22MAy w/rash in diaper area, on face, chest, back, abdomen; Pinpoint pale pink rash, macular; child acts okay, eats okay; no inc temp;
Lemon sized lump/hives-like, red, itchy, fever for 4 days
local irritation to right deltoid area slight redness and inflammation 2 x 3" since injection on 08/11/2005. Some sorness. Treated with motrin, compresses, monitor to return if symptome increase or fever.
she got a golf-ball, ping-pong ball underneath her arm. It's swelling.; didn't feel great; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (she got a golf-ball, ping-pong ball underneath her arm. It's swelling.) and FEELING ABNORMAL (didn't feel great) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 03-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Nov-2021, the patient experienced FEELING ABNORMAL (didn't feel great). On 24-Nov-2021, the patient experienced SWELLING (she got a golf-ball, ping-pong ball underneath her arm. It's swelling.). At the time of the report, SWELLING (she got a golf-ball, ping-pong ball underneath her arm. It's swelling.) had not resolved and FEELING ABNORMAL (didn't feel great) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.
Information was received on 13-OCT-2017 from a lawyer regarding a case in litigation concerning a male patient of unknown age. Medical history, concurrent conditions, and concomitant medications were not provided. It was reported that the patient was vaccinated with a dose of ZOSTAVAX (lot number, dosage, and route of administration not provided) on or about 04-JUN-2012 at a VA facility as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. On or about 13-AUG-2015, the patient was treated by a physician for the onset of a severe vesicular rash accompanied by weakened immune symptoms, which was diagnosed as herpes zoster, or shingles. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages and required extensive medical care and treatment. As a further proximate result the patient has suffered and will continue to suffer significant medical expenses, pain and suffering and other damages. Additional information has been requested.
No adverse reaction-received (2) flu vaccine instead of one in 2014. Pt. received flu vaccine on 9/18/14 and also, received a flu vaccine on 11/17/14.
Headache Headaches, Joint pain, Muscle pains , fatigue, Brain Fog Narrative:
arrhythmia, heart palpitations, pain in left arm, pain in chest (particularly left side) radiating into shoulder blade, fatigue, muscle aches
Around 3:30 PM the client's employer called and reported that patient was having chills, lower back pain, nausea, and joint pain. They reported that she had vomited one time. They checked her BP and her temp and reported that she did not have a fever or any abnormal BP values. Writer spoke with client and she reported that she did not have any rashes and was not having any difficulty breathing.
Onset of leg weakness and instability that has progressively worsened. Constant imbalance noted more in standing and with walking resulting in feeling like I am "rocking on a boat" constantly. Increased sway in static standing that is more pronounced with rotational movements, eyes closed, and decreased base of support. Ataxic movements and lateral veering with walking at times. Episodes of low blood pressure/significant decrease in blood pressure from sitting to standing, tachycardia, and resting tremors in the hands that are intermittent in nature. Feeling of head being "in the clouds" constantly where something is not right.
REDNESS AND WARMTH TO INJECTION SITE. INSTRUCTED MOM TO BRING CHILD BACK IN TO BE OBSERVED BY DOCTOR. UPON RETURNING DOCTOR OBSERVED INJECTION AREA AND REACTION AND INFORMED MOM TO APPLY COLD COMPRESS TO AREA FOR SHORT PERIODS OF TIME AND ADMINISTER TYLENOL TO HELP WITH DISCOMFORT. MOM VOICED UNDERSTANDING.
Severe pain started 4 hours post injection, Pain progressively got worse, developed knot at immunization site, limited Range of motion in shoulder due to pain